Testing NRX-101 with TMS for treatment-resistant depression
Part of Mental health clinical trials.
This study tests if adding the drug NRX-101 to a new type of brain stimulation (TMS) helps adults with depression that hasn't improved with other treatments. You must be new to TMS and have tried at least two antidepressants without success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with major depressive disorder and it has not improved after trying at least two different antidepressants.
- You are about to start transcranial magnetic stimulation (TMS) for the first time.
- You have a caregiver who can support you during the study.
- You are not pregnant, breastfeeding, or able to become pregnant and using effective birth control.
- You are not taking certain medications or have certain medical conditions (like unstable diabetes, heart disease, or a history of seizures).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This expanded access program offers the combination of NRX-101 and theta burst transcranial magnetic stimulation (TMS) for people with treatment-resistant depression who cannot participate in a related clinical trial. It aims to provide treatment access while monitoring safety and effectiveness.
This trial tests a personalized brain stimulation method called neuronavigated aiTBS for people with depression that hasn't improved with at least two prior treatments. The goal is to see if this therapy can safely and effectively reduce depressive symptoms.
This trial tests two different ways of delivering transcranial magnetic stimulation (TMS) to see which works better for people with depression that hasn't improved with medication.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This study tests whether adding TMS to ECT can better treat depression that hasn't improved with other treatments. It is for adults with moderate to severe major depression who haven't had these treatments recently.
This trial studies signs in the brain (biomarkers) during an accelerated form of nerve stimulation to treat depression that hasn’t improved with usual antidepressants. It may help researchers learn who benefits and how to better personalize treatment.
Hear when a new Treatment Resistant Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.